GB828847A
(en)
|
1956-12-14 |
1960-02-24 |
Ilford Ltd |
Improvements in or relating to cyanine dyes
|
FR1242962A
(fr)
|
1959-08-25 |
1960-10-07 |
Kodak Pathe |
Nouveau procédé pour la préparation de colorants sensibilisateurs de la série des cyanines et des mérocyanines et produits obtenus
|
GB1268773A
(en)
|
1968-03-15 |
1972-03-29 |
Glaxo Lab Ltd |
NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
|
US3710795A
(en)
|
1970-09-29 |
1973-01-16 |
Alza Corp |
Drug-delivery device with stretched, rate-controlling membrane
|
GB1429184A
(en)
|
1972-04-20 |
1976-03-24 |
Allen & Hanburys Ltd |
Physically anti-inflammatory steroids for use in aerosols
|
US4044126A
(en)
|
1972-04-20 |
1977-08-23 |
Allen & Hanburys Limited |
Steroidal aerosol compositions and process for the preparation thereof
|
USRE28819E
(en)
|
1972-12-08 |
1976-05-18 |
Syntex (U.S.A.) Inc. |
Dialkylated glycol compositions and medicament preparations containing same
|
JPS54110226A
(en)
|
1978-01-25 |
1979-08-29 |
Bayer Ag |
Dye
|
DE2844606A1
(de)
|
1978-10-13 |
1980-04-24 |
Bayer Ag |
Heterocyclische farbstoffe
|
US4328245A
(en)
|
1981-02-13 |
1982-05-04 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
US4410545A
(en)
|
1981-02-13 |
1983-10-18 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
US4358603A
(en)
|
1981-04-16 |
1982-11-09 |
Syntex (U.S.A.) Inc. |
Acetal stabilized prostaglandin compositions
|
US4409239A
(en)
|
1982-01-21 |
1983-10-11 |
Syntex (U.S.A.) Inc. |
Propylene glycol diester solutions of PGE-type compounds
|
GB9222253D0
(en)
|
1992-10-23 |
1992-12-09 |
Celltech Ltd |
Chemical compounds
|
GB9304920D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
KR100437582B1
(ko)
*
|
1995-07-06 |
2004-12-17 |
노파르티스 아게 |
피롤로피리미딘및그들의제조방법
|
US6716575B2
(en)
|
1995-12-18 |
2004-04-06 |
Sugen, Inc. |
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
|
US7119174B2
(en)
|
1995-12-18 |
2006-10-10 |
Sugen, Inc. |
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
|
EP0868519B1
(en)
|
1995-12-18 |
2006-01-11 |
Sugen, Inc. |
Diagnosis and treatment of aur-1 and/or aur-2 related disorders
|
GB9707800D0
(en)
|
1996-05-06 |
1997-06-04 |
Zeneca Ltd |
Chemical compounds
|
EP0923581B1
(en)
*
|
1996-08-09 |
2003-05-21 |
Boehringer Ingelheim Pharmaceuticals Inc. |
4-substituted beta-carbolines as immunomodulators
|
GB9622363D0
(en)
|
1996-10-28 |
1997-01-08 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9625184D0
(en)
|
1996-12-04 |
1997-01-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
AU5330698A
(en)
|
1996-12-23 |
1998-07-17 |
Celltech Therapeutics Limited |
Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
|
GB9705361D0
(en)
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
DE69836220T2
(de)
|
1997-08-15 |
2007-08-30 |
Hiroshima University |
Den zellzyklus regulierende proteine
|
AU8816298A
(en)
|
1997-08-22 |
1999-03-16 |
Zeneca Limited |
Oxindolylquinazoline derivatives as angiogenesis inhibitors
|
US7462605B2
(en)
|
1998-01-23 |
2008-12-09 |
Celmed Oncology (Usa), Inc. |
Phosphoramidate compounds and methods of use
|
US6143480A
(en)
|
1998-09-03 |
2000-11-07 |
Fuji Photo Film Co., Ltd. |
Leuco dye and image recording medium containing the same
|
US6706491B1
(en)
|
1999-04-09 |
2004-03-16 |
The Board Of Trustees Of The University Of Illinois |
Reagents and methods for identifying and modulating expression of genes regulated by p21
|
US20050113460A1
(en)
|
1999-04-30 |
2005-05-26 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
US6982265B1
(en)
|
1999-05-21 |
2006-01-03 |
Bristol Myers Squibb Company |
Pyrrolotriazine inhibitors of kinases
|
AU6237700A
(en)
|
1999-07-21 |
2001-02-13 |
University Of Massachusetts |
Kinase blocking polypeptides and uses thereof
|
WO2001014378A1
(fr)
|
1999-08-23 |
2001-03-01 |
Shionogi & Co., Ltd. |
DERIVES DE PYRROLOTRIAZINE A ACTIVITES INHIBANT sPLA¿2?
|
GB9922173D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
AU763242B2
(en)
|
1999-09-21 |
2003-07-17 |
Astrazeneca Ab |
Quinazoline compounds and pharmaceutical compositions containing them
|
GB9922171D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
WO2001021596A1
(en)
|
1999-09-21 |
2001-03-29 |
Astrazeneca Ab |
Quinazoline derivatives and their use as pharmaceuticals
|
WO2001025220A1
(en)
|
1999-10-07 |
2001-04-12 |
Amgen Inc. |
Triazine kinase inhibitors
|
US6455525B1
(en)
|
1999-11-04 |
2002-09-24 |
Cephalon, Inc. |
Heterocyclic substituted pyrazolones
|
DZ3377A1
(fr)
|
1999-12-24 |
2001-07-05 |
Aventis Pharma Ltd |
Azaindoles
|
US6977259B2
(en)
|
2000-01-28 |
2005-12-20 |
Astrazeneca Ab |
Quinoline derivatives and their use as aurora 2 kinase inhibitors
|
BR0104424A
(pt)
|
2000-02-05 |
2002-01-08 |
Vertex Pharma |
Composições de pirazol úteis como inibidores de erk
|
JP4739632B2
(ja)
|
2000-02-05 |
2011-08-03 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Erkのインヒビターとして有用なピラゾール組成物
|
EP1209158A1
(en)
|
2000-11-18 |
2002-05-29 |
Aventis Pharma Deutschland GmbH |
Substituted beta-carbolines
|
EP1134221A1
(en)
|
2000-03-15 |
2001-09-19 |
Aventis Pharma Deutschland GmbH |
Substituted beta-carbolines as lkB kinase inhibitors
|
PL357284A1
(en)
*
|
2000-03-15 |
2004-07-26 |
Aventis Pharma Deutschland Gmbh |
Substituted beta-carbolines with ikb-kinase inhibiting activity
|
JP2001294772A
(ja)
|
2000-04-10 |
2001-10-23 |
Fuji Photo Film Co Ltd |
着色組成物、インクジェット用インク及びインクジェット記録方法
|
JP2001302667A
(ja)
|
2000-04-28 |
2001-10-31 |
Bayer Ag |
イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体
|
US6555329B2
(en)
|
2000-06-09 |
2003-04-29 |
Boehringer Ingelheim International Gmbh |
Method for identifying compounds altering higher-order chromatin-dependent chromosome stability
|
US6335342B1
(en)
|
2000-06-19 |
2002-01-01 |
Pharmacia & Upjohn S.P.A. |
Azaindole derivatives, process for their preparation, and their use as antitumor agents
|
EE200200715A
(et)
|
2000-06-28 |
2004-08-16 |
Astrazeneca Ab |
Asendatud kinasoliini derivaadid ja nende kasutamine inhibiitoritena
|
AU2002222933A1
(en)
|
2000-07-13 |
2002-01-30 |
Millennium Pharamaceuticals, Inc. |
Inhibitors of factor xa
|
US20050009876A1
(en)
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
EP1320531B1
(en)
|
2000-08-10 |
2010-09-08 |
Pfizer Italia S.r.l. |
Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
US6352858B1
(en)
|
2000-09-11 |
2002-03-05 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of BTAK expression
|
US6660731B2
(en)
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US6613776B2
(en)
|
2000-09-15 |
2003-09-02 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US6610677B2
(en)
|
2000-09-15 |
2003-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
WO2002022605A1
(en)
|
2000-09-15 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US7473691B2
(en)
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
AU2002215053A1
(en)
|
2000-11-27 |
2002-06-24 |
Pharmacia Italia S.P.A. |
Phenylacetamido- pyrazole derivatives and their use as antitumor agents
|
US6455559B1
(en)
|
2001-07-19 |
2002-09-24 |
Pharmacia Italia S.P.A. |
Phenylacetamido-pyrazole derivatives, process for their preparation and their use as antitumor agents
|
NZ525788A
(en)
|
2000-11-28 |
2004-11-26 |
Pfizer Prod Inc |
Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
|
FR2818278B1
(fr)
|
2000-12-20 |
2003-02-28 |
Sod Conseils Rech Applic |
Inhibiteurs de kinases dependantes des cyclines (cdk) et de la glycogene synthase kinase-3 (gsk-3)
|
CA2432417A1
(fr)
|
2000-12-20 |
2002-06-27 |
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R .A.S.) |
Inhibiteurs de kinases dependantes des cylines (cdk) et de la glycogene synthase kinase-3 (gsk-3)
|
US6989385B2
(en)
|
2000-12-21 |
2006-01-24 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
GB0102687D0
(en)
|
2001-02-02 |
2001-03-21 |
Pharmacia & Upjohn Spa |
Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
|
MY130778A
(en)
|
2001-02-09 |
2007-07-31 |
Vertex Pharma |
Heterocyclic inhibitiors of erk2 and uses thereof
|
US6864255B2
(en)
|
2001-04-11 |
2005-03-08 |
Amgen Inc. |
Substituted triazinyl amide derivatives and methods of use
|
DE60205742T2
(de)
|
2001-05-14 |
2006-05-11 |
Pfizer Products Inc., Groton |
Tartratsalze von 5,8,14-Triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaen
|
WO2002094809A1
(en)
|
2001-05-24 |
2002-11-28 |
Yamanouchi Pharmaceutical Co., Ltd. |
3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
|
AU2002310187A1
(en)
|
2001-05-30 |
2002-12-09 |
Lg Biomedical Institute |
Inhibitors of protein kinase for the treatment of disease
|
US6762179B2
(en)
|
2001-05-31 |
2004-07-13 |
Vertex Pharmaceuticals Incorporated |
Thiazole compounds useful as inhibitors of protein kinase
|
ATE339418T1
(de)
|
2001-06-01 |
2006-10-15 |
Vertex Pharma |
Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
MXPA03011950A
(es)
|
2001-06-22 |
2004-03-26 |
Procter & Gamble |
Composiciones para el cuidado de telas en sistemas de fluidos lipofilicos.
|
GB0115393D0
(en)
|
2001-06-23 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
PL367938A1
(en)
|
2001-07-19 |
2005-03-07 |
Pharmacia Italia S.P.A. |
Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
|
WO2003009852A1
(en)
|
2001-07-24 |
2003-02-06 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
WO2003012046A2
(en)
|
2001-07-27 |
2003-02-13 |
The Regents Of The University Of California |
Stk15 (stk6) gene polymorphism and methods of determining cancer risk
|
WO2003011287A1
(en)
|
2001-08-03 |
2003-02-13 |
Vertex Pharmaceuticals Incorporated |
Pyrazolon derivatives as inhibitors of gsk-3
|
NZ530782A
(en)
|
2001-08-06 |
2005-11-25 |
Pharmacia Italia S |
Aminoisoxazole derivatives active as kinase inhibitors
|
US20030073692A1
(en)
|
2001-08-07 |
2003-04-17 |
Pharmacia & Upjohn S.P.A. |
Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
|
WO2003020276A1
(en)
|
2001-08-30 |
2003-03-13 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
US6806272B2
(en)
|
2001-09-04 |
2004-10-19 |
Boehringer Ingelheim Pharma Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
JP2005506983A
(ja)
|
2001-09-19 |
2005-03-10 |
ファルマシア・コーポレーション |
炎症の治療のための置換ピラゾリル化合物
|
ES2286275T3
(es)
|
2001-09-19 |
2007-12-01 |
Pharmacia Corporation |
Compuestos de pirazolo sustituidos para el tratamiento de la inflamacion.
|
EP1427707A1
(en)
|
2001-09-19 |
2004-06-16 |
Pharmacia Corporation |
Substituted indazole compounds for the treatment of inflammation
|
BR0212661A
(pt)
|
2001-09-19 |
2004-08-24 |
Pharmacia Corp |
Compostos de pirazolil benzenossulfamida substituìdos para o tratamento de inflamação
|
KR20040047869A
(ko)
|
2001-09-26 |
2004-06-05 |
파마시아 이탈리아 에스.피.에이. |
키나제 억제제로서 활성인 아미노인다졸 유도체, 이의제조방법 및 이를 함유하는 약제학적 조성물
|
GB0124299D0
(en)
|
2001-10-10 |
2001-11-28 |
Astrazeneca Ab |
Crystal structure of enzyme and uses thereof
|
CA2463989C
(en)
|
2001-10-17 |
2012-01-31 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof
|
US20040010027A1
(en)
|
2001-12-17 |
2004-01-15 |
Pharmacia & Upjohn Spa |
Hydroxphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical comositions comprising them
|
SE0104340D0
(sv)
|
2001-12-20 |
2001-12-20 |
Astrazeneca Ab |
New compounds
|
CA2471577C
(en)
|
2001-12-24 |
2011-08-02 |
Astrazeneca Ab |
Chemical compounds
|
KR101004224B1
(ko)
|
2002-02-01 |
2010-12-27 |
어리어드 파마슈티칼스, 인코포레이티드 |
인 함유 화합물 및 이의 용도
|
FR2836914B1
(fr)
|
2002-03-11 |
2008-03-14 |
Aventis Pharma Sa |
Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
AU2003225800A1
(en)
|
2002-03-15 |
2003-09-29 |
Hayley Binch |
Azolylaminoazine as inhibitors of protein kinases
|
US7091343B2
(en)
|
2002-03-15 |
2006-08-15 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
US20040009981A1
(en)
|
2002-03-15 |
2004-01-15 |
David Bebbington |
Compositions useful as inhibitors of protein kinases
|
ES2289279T3
(es)
|
2002-03-15 |
2008-02-01 |
Vertex Pharmaceuticals Incorporated |
Composiciones utiles como inhibidores de proteinquinasas.
|
SE0200979D0
(sv)
|
2002-03-28 |
2002-03-28 |
Astrazeneca Ab |
New compounds
|
US20050130977A1
(en)
|
2002-04-08 |
2005-06-16 |
Lindsley Craig W. |
Inhibitors of akt activity
|
WO2003087395A2
(en)
|
2002-04-15 |
2003-10-23 |
Inserm |
Methods to identify anti-tumoral agents inhibiting rasgap / aurora kinase interactions
|
EP1506189A1
(en)
|
2002-04-26 |
2005-02-16 |
Vertex Pharmaceuticals Incorporated |
Pyrrole derivatives as inhibitors of erk2 and uses thereof
|
ES2340475T3
(es)
|
2002-05-01 |
2010-06-04 |
Vertex Pharmaceuticals Incorporated |
Estructura cristalizada de proteina aurora-2 y sus bolsillos de union.
|
ES2411655T3
(es)
|
2002-05-17 |
2013-07-08 |
Pfizer Italia S.R.L. |
Derivados de aminoindazol activos como inhibidores de quinasas, procedimiento para su preparación y composiciones farmacéuticas que los comprenden
|
JPWO2003101983A1
(ja)
*
|
2002-05-31 |
2005-09-29 |
アステラス製薬株式会社 |
テトラヒドロピラン誘導体
|
US6989451B2
(en)
|
2002-06-04 |
2006-01-24 |
Valeant Research & Development |
Heterocyclic compounds and uses thereof
|
AU2002311176A1
(en)
|
2002-06-12 |
2003-12-31 |
Axia Biosciences, Inc. |
Chfr protein-catalyzed polyubiquitination of aurora kinase a and aurora kinase b
|
FR2840905B1
(fr)
|
2002-06-12 |
2006-07-07 |
Centre Nat Rech Scient |
Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers
|
CA2486215A1
(en)
|
2002-06-14 |
2003-12-24 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
CA2491895C
(en)
|
2002-07-09 |
2011-01-18 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
|
AU2003253880A1
(en)
|
2002-07-15 |
2004-02-02 |
Sugen, Inc. |
Novel kinases
|
ATE393159T1
(de)
|
2002-07-17 |
2008-05-15 |
Pfizer Italia Srl |
Heterobicyclische pyrazolderivate als kinaseinhibitoren
|
CA2493637A1
(en)
|
2002-07-25 |
2004-02-12 |
Manuela Villa |
Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
MXPA05000947A
(es)
|
2002-07-25 |
2005-05-16 |
Pharmacia Italia Spa |
Biciclo-pirazoles activos como inhibidores de cinasa, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
|
BR0312961A
(pt)
|
2002-07-25 |
2005-06-14 |
Pharmacia Italia Spa |
Derivados condensados heterociclicos de pirazol como inibidores de cinase
|
CA2495386C
(en)
|
2002-08-14 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
PE20050081A1
(es)
|
2002-09-23 |
2005-03-01 |
Schering Corp |
Nuevas imidazopirazinas como inhibidores de cinasas dependientes de ciclinas
|
WO2004035577A2
(en)
|
2002-10-16 |
2004-04-29 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
US7262200B2
(en)
|
2002-10-25 |
2007-08-28 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
US20040102360A1
(en)
|
2002-10-30 |
2004-05-27 |
Barnett Stanley F. |
Combination therapy
|
GB0226583D0
(en)
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Compounds
|
US6909001B2
(en)
|
2002-12-12 |
2005-06-21 |
Pharmacia Corporation |
Method of making tricyclic aminocyanopyridine compounds
|
UA81790C2
(uk)
|
2002-12-19 |
2008-02-11 |
Фармация Италия С.П.А. |
Заміщені піролопіразольні похідні як інгібітори кінази
|
AU2003292435A1
(en)
|
2002-12-23 |
2004-07-14 |
Astrazeneca Ab |
4- (pyridin-4-ylamino) -quinazoline derivatives as anti-tumor agents
|
ATE438644T1
(de)
|
2002-12-24 |
2009-08-15 |
Astrazeneca Ab |
Chinazolinderivate
|
CN1753889A
(zh)
|
2002-12-24 |
2006-03-29 |
阿斯利康(瑞典)有限公司 |
喹唑啉化合物
|
DE60324461D1
(de)
|
2002-12-24 |
2008-12-11 |
Astrazeneca Ab |
Therapeutische quinazolin-derivate
|
CL2004000016A1
(es)
|
2003-01-21 |
2005-04-15 |
Wyeth Corp |
Compuesto derivado de cloruro de 4-amino-2-butenoilo o una sal farmaceuticamente aceptable del mismo; procedimiento para preparar dicho compuesto, util como intermediario en la sintesis de compuestos inhibidores de proteina quinasa tirosina.
|
ATE440087T1
(de)
|
2003-01-30 |
2009-09-15 |
Boehringer Ingelheim Pharma |
2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
|
WO2004070062A2
(en)
|
2003-02-04 |
2004-08-19 |
Wyeth |
Compositions and methods for diagnosing and treating cancers
|
CA2513716A1
(en)
|
2003-02-14 |
2004-08-26 |
Applied Research Systems Ars Holding N.V. |
Piperazine-2-carboxamide derivatives
|
WO2004071507A1
(en)
|
2003-02-17 |
2004-08-26 |
Pharmacia Italia S.P.A. |
Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
US6861422B2
(en)
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
CN100537570C
(zh)
|
2003-02-26 |
2009-09-09 |
贝林格尔英格海姆法玛两合公司 |
二氢蝶啶酮、其制法及作为药物制剂的用途
|
WO2006018628A1
(en)
|
2003-03-07 |
2006-02-23 |
Astrazeneca Ab |
Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer
|
EP1608364A1
(en)
|
2003-03-11 |
2005-12-28 |
Pharmacia Italia S.p.A. |
Bicyclo-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
WO2004083203A1
(en)
|
2003-03-13 |
2004-09-30 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as protein kinase inhibitors
|
WO2004087056A2
(en)
|
2003-03-28 |
2004-10-14 |
Scios Inc. |
BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ
|
US20070179161A1
(en)
|
2003-03-31 |
2007-08-02 |
Vernalis (Cambridge) Limited. |
Pyrazolopyrimidine compounds and their use in medicine
|
WO2004090106A2
(en)
|
2003-04-04 |
2004-10-21 |
Vertex Pharmaceuticals Incorporated |
Crystal structures of human pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design
|
CA2521300A1
(en)
*
|
2003-04-09 |
2004-10-28 |
Millennium Pharmaceuticals, Inc. |
Beta-carbolines useful for treating inflammatory disease
|
CA2522023A1
(en)
*
|
2003-04-11 |
2004-10-21 |
Glenmark Pharmaceuticals S.A. |
Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
|
US7691867B2
(en)
|
2003-04-16 |
2010-04-06 |
Astrazeneca Ab |
Chemical compounds
|
US7304063B2
(en)
|
2003-04-24 |
2007-12-04 |
Merck & Co., Inc. |
Inhibitors of Akt activity
|
CN1809354A
(zh)
|
2003-04-24 |
2006-07-26 |
麦克公司 |
Akt活性抑制剂
|
JP4679514B2
(ja)
|
2003-04-24 |
2011-04-27 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Akt活性の阻害剤
|
EP1620095A4
(en)
|
2003-04-24 |
2009-04-01 |
Merck & Co Inc |
INHIBITORS OF AKT ACTIVITY
|
US20040242559A1
(en)
|
2003-04-25 |
2004-12-02 |
Aventis Pharma S.A. |
Novel indole derivatives, preparation thereof as medicinal products and pharmaceutical compositions, and especially as KDR inhibitors
|
ATE482200T1
(de)
|
2003-05-01 |
2010-10-15 |
Bristol Myers Squibb Co |
Als kinaseinhibitoren geeignete arylsubstituierte pyrazolamidverbindungen
|
WO2005004988A2
(en)
|
2003-05-01 |
2005-01-20 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
WO2005000200A2
(en)
|
2003-05-09 |
2005-01-06 |
Sugen, Inc. |
Novel kinases
|
ES2436524T3
(es)
|
2003-05-22 |
2014-01-02 |
Nerviano Medical Sciences S.R.L. |
Derivados de pirazolo-quinazolina, procedimiento para su preparación y su uso como inhibidores de cinasas
|
US7345046B2
(en)
|
2003-05-30 |
2008-03-18 |
Chiron Corporation |
Heteroaryl-fused pyrimidinyl compounds as anticancer agents
|
EP1635837B1
(en)
|
2003-06-02 |
2008-07-16 |
AstraZeneca AB |
(3-((quinazolin-4-yl)amino)-1h-pyrazol-1-yl)acetamide derivatives and related compounds as aurora kinase inhibitors for the treatment of proliferative diseases such as cancer
|
TW200505452A
(en)
|
2003-06-17 |
2005-02-16 |
Astrazeneca Ab |
Chemical compounds
|
CN1809563A
(zh)
|
2003-06-20 |
2006-07-26 |
希龙公司 |
吡啶并[1,2-a]嘧啶-4-酮化合物用作抗癌药
|
WO2005009348A2
(en)
|
2003-06-25 |
2005-02-03 |
Ariad Pharmaceuticals, Inc. |
Substituted purine derivatives
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
GB0315657D0
(en)
|
2003-07-03 |
2003-08-13 |
Astex Technology Ltd |
Pharmaceutical compounds
|
ES2322707T3
(es)
|
2003-07-03 |
2009-06-25 |
Euro-Celtique S.A. |
Derivados de 2-piridina alquino utiles para tratar el dolor.
|
US20060178318A1
(en)
|
2003-07-03 |
2006-08-10 |
Shubha Anand |
Use of aurora kinase inhibitors for reducing the resistance of cancer cells
|
GB0315966D0
(en)
|
2003-07-08 |
2003-08-13 |
Cyclacel Ltd |
Compounds
|
US20050032869A1
(en)
|
2003-07-08 |
2005-02-10 |
Pharmacia Italia S.P.A. |
Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
US7141568B2
(en)
|
2003-07-09 |
2006-11-28 |
Pfizer Italia S.R.L. |
Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
WO2005016252A2
(en)
|
2003-07-11 |
2005-02-24 |
Ariad Gene Therapeutics, Inc. |
Phosphorus-containing macrocycles
|
ES2317031T3
(es)
|
2003-07-16 |
2009-04-16 |
Janssen Pharmaceutica Nv |
Derivados de triazolopirimidina como inhibidores de la glucogeno-sintasa-quinasa 3.
|
CA2531333A1
(en)
|
2003-07-16 |
2005-02-10 |
Janssen Pharmaceutica N.V. |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
|
JP5198768B2
(ja)
|
2003-07-21 |
2013-05-15 |
メルク セローノ ソシエテ アノニム |
アルキニルアリールカルボキサミド
|
US20050137220A1
(en)
*
|
2003-07-23 |
2005-06-23 |
Pharmacia Corporation |
Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
|
BRPI0412808A
(pt)
|
2003-07-24 |
2006-09-26 |
Euro Celtique Sa |
compostos de piperidina e composições farmacêuticas contendo os mesmos
|
US20050026984A1
(en)
|
2003-07-29 |
2005-02-03 |
Aventis Pharma S.A. |
Substituted thieno [2,3-c] pyrazoles and their use as medicinal products
|
US7619059B2
(en)
|
2003-07-29 |
2009-11-17 |
Life Technologies Corporation |
Bimolecular optical probes
|
CA2533474A1
(en)
|
2003-07-30 |
2005-02-10 |
Shudong Wang |
2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
|
BRPI0412351A
(pt)
|
2003-07-30 |
2006-09-05 |
Cyclacel Ltd |
derivados e piridilamino-pirimidina como inibidores de proteìna quinase
|
US7094791B2
(en)
|
2003-07-31 |
2006-08-22 |
Avalon Pharmaceuticals, Inc. |
Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof
|
US7279575B2
(en)
|
2003-08-08 |
2007-10-09 |
Pfizer Italia S.R.L. |
Pyrimidylpyrrole derivatives active as kinase inhibitors
|
US20050043346A1
(en)
|
2003-08-08 |
2005-02-24 |
Pharmacia Italia S.P.A. |
Pyridylpyrrole derivatives active as kinase inhibitors
|
JP2007512230A
(ja)
|
2003-08-20 |
2007-05-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼ阻害剤として有用な(4−アミノ−1,2,5−オキサジアゾール−4−イル)−ヘテロ芳香族化合物
|
AR045595A1
(es)
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
EP1667995A1
(en)
|
2003-09-12 |
2006-06-14 |
Applied Research Systems ARS Holding N.V. |
Benzimidazole acetonitriles
|
EP1667996B1
(en)
|
2003-09-16 |
2009-07-22 |
Astrazeneca AB |
Quinazoline derivatives
|
DK1667991T3
(da)
|
2003-09-16 |
2008-08-18 |
Astrazeneca Ab |
Quinazolinderivater som tyrosinkinaseinhibitorer
|
EP1664030A1
(en)
|
2003-09-16 |
2006-06-07 |
AstraZeneca AB |
Quinazoline derivatives
|
CA2539064A1
(en)
|
2003-09-17 |
2005-04-21 |
Sunesis Pharmaceuticals, Inc. |
Identification of kinase inhibitors
|
KR20070064414A
(ko)
|
2003-09-17 |
2007-06-20 |
이코스 코포레이션 |
세포 증식 제어를 위한 chk1 억제제의 용도
|
ATE433974T1
(de)
|
2003-09-19 |
2009-07-15 |
Gilead Sciences Inc |
Azachinolinolphosphonatverbindungen als integraseinhibitoren
|
US20050085531A1
(en)
|
2003-10-03 |
2005-04-21 |
Hodge Carl N. |
Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
|
MXPA06003746A
(es)
|
2003-10-14 |
2006-06-14 |
Pharmacia Corp |
Compuestos de pirazinona sustituida para el tratamiento de inflamacion.
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
SI1678166T1
(sl)
|
2003-10-14 |
2009-10-31 |
Univ Arizona State |
Inhibitorji proteinske kinaze
|
EP1678169B1
(en)
|
2003-10-17 |
2009-07-22 |
Astrazeneca AB |
4-(pyrazol-3-ylamino)pyrimidine derivatives for use in the treatment of cancer
|
WO2005037797A1
(en)
|
2003-10-21 |
2005-04-28 |
Pharmacia Corporation |
Substituted pyrazole urea compounds for the treatment of inflammation
|
AU2004285745A1
(en)
|
2003-10-21 |
2005-05-12 |
Cyclacel Limited |
Pyrimidin-4-YL-3, 4-thione compounds and their use in therapy
|
BRPI0415678A
(pt)
|
2003-10-23 |
2006-12-19 |
Pharmacia Corp |
compostos de pirimidina para o tratamento de inflamação
|
WO2005044270A1
(en)
|
2003-11-04 |
2005-05-19 |
4Sc Ag |
Oxadiazolopyrazine derivatives as pharmaceutically active compounds
|
EP1692113B1
(en)
|
2003-11-14 |
2017-09-27 |
Lorus Therapeutics Inc. |
Aryl imidazoles and their use as anti-cancer agents
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
WO2005051308A2
(en)
|
2003-11-19 |
2005-06-09 |
Signal Pharmaceuticals, Llc |
Methods of treating diseases and disorders by targeting multiple kinases
|
FR2864084B1
(fr)
|
2003-12-17 |
2006-02-10 |
Aventis Pharma Sa |
Nouveaux derives organophosphores des indazoles et leur utilisation comme medicaments
|
EP1713814A1
(en)
|
2003-12-17 |
2006-10-25 |
SGX Pharmaceuticals, Inc. |
Bicyclic pyrazolo-fused compounds as protein kinase modulators
|
GB0330042D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them
|
GB0330043D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
|
EP1704416A2
(en)
|
2004-01-16 |
2006-09-27 |
Ipsogen |
Protein expression profiling and breast cancer prognosis
|
US7855295B2
(en)
|
2004-01-23 |
2010-12-21 |
Novartis Vaccines And Diagnostics, Inc. |
Tetrahydrocarboline compounds as anticancer agents
|
TW200526204A
(en)
|
2004-02-03 |
2005-08-16 |
Pharmacia Italia Spa |
1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
|
FR2865934B1
(fr)
|
2004-02-05 |
2006-05-05 |
Sanofi Synthelabo |
Utilisation de derives d'indolizine 1,2,3 substitues, inhibiteurs des fgfs, pour la preparation de medicaments utiles pour le traitement de maladies liees a une angiogenese pathologique choroidienne
|
GB0402653D0
(en)
|
2004-02-06 |
2004-03-10 |
Cyclacel Ltd |
Compounds
|
PE20051128A1
(es)
|
2004-02-25 |
2006-01-16 |
Schering Corp |
Pirazolotriazinas como inhibidores de quinasa
|
JP2007530589A
(ja)
|
2004-03-26 |
2007-11-01 |
アンフォラ ディスカバリー コーポレーション |
特定のトリアゾールを基礎とする化合物、組成物、およびそれらの使用
|
WO2005094830A1
(en)
|
2004-03-30 |
2005-10-13 |
Pfizer Products Inc. |
Combinations of signal transduction inhibitors
|
CN101676285A
(zh)
|
2004-03-30 |
2010-03-24 |
沃泰克斯药物股份有限公司 |
用作jak和其它蛋白激酶抑制剂的氮杂吲哚
|
FR2868421B1
(fr)
|
2004-04-01 |
2008-08-01 |
Aventis Pharma Sa |
Nouveaux benzothiazoles et leur utilisation comme medicaments
|
WO2005105788A1
(en)
|
2004-04-23 |
2005-11-10 |
Takeda San Diego, Inc. |
Indole derivatives and use thereof as kinase inhibitors
|
AU2005249380C1
(en)
|
2004-04-23 |
2012-09-20 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
TW200538453A
(en)
|
2004-04-26 |
2005-12-01 |
Bristol Myers Squibb Co |
Bicyclic heterocycles as kinase inhibitors
|
WO2005105777A1
(en)
|
2004-05-05 |
2005-11-10 |
Pharmacia & Upjohn Company Llc |
Substituted thiophene amide compounds for the treatment of inflammation
|
JP5097539B2
(ja)
|
2004-05-07 |
2012-12-12 |
アムジエン・インコーポレーテツド |
タンパク質キナーゼ調節剤および使用方法
|
US7572784B2
(en)
|
2004-05-14 |
2009-08-11 |
Millennium Pharmaceuticals, Inc. |
Compounds and methods for inhibiting mitotic progression
|
EP1763514A2
(en)
|
2004-05-18 |
2007-03-21 |
Rigel Pharmaceuticals, Inc. |
Cycloalkyl substituted pyrimidinediamine compounds and their uses
|
EP1598343A1
(de)
|
2004-05-19 |
2005-11-23 |
Boehringer Ingelheim International GmbH |
2-Arylaminopyrimidine als PLK Inhibitoren
|
WO2005113550A1
(ja)
|
2004-05-20 |
2005-12-01 |
Mitsubishi Pharma Corporation |
アミノピリミジン誘導体及びその医薬としての用途
|
AU2005245492A1
(en)
|
2004-05-21 |
2005-12-01 |
Novartis Vaccines And Diagnostics, Inc. |
Substituted quinoline derivatives as mitotic kinesin inhibitors
|
JP2008500057A
(ja)
|
2004-05-27 |
2008-01-10 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Impdh経路の阻害をモニタリングするためのバイオマーカー
|
WO2005118587A1
(en)
|
2004-06-02 |
2005-12-15 |
Takeda Pharmaceutical Company Limited |
Indole derivative and use for treatment of cancer
|
US7452887B2
(en)
|
2004-06-04 |
2008-11-18 |
Amphora Discovery Corporation |
Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
|
FR2871158A1
(fr)
|
2004-06-04 |
2005-12-09 |
Aventis Pharma Sa |
Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
CA2569277A1
(en)
|
2004-06-04 |
2005-12-15 |
Pfizer Products Inc. |
Method for treating abnormal cell growth
|
EP1773807A2
(en)
|
2004-06-14 |
2007-04-18 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
WO2005123696A1
(en)
|
2004-06-15 |
2005-12-29 |
Astrazeneca Ab |
Substituted quinazolones as anti-cancer agents
|
RU2427572C2
(ru)
|
2004-06-18 |
2011-08-27 |
Чирон Корпорейшн |
N-(1-(1-бензил-4-фенил-1н-имидазол-2-ил)-2,2-диметилпропил)бензамидные производные и родственные соединения в качестве ингибиторов кинезинового белка веретена (ksp) для лечения рака
|
DE102004029784A1
(de)
|
2004-06-21 |
2006-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
|
RU2007102226A
(ru)
|
2004-06-23 |
2008-07-27 |
Айрм Ллк (Bm) |
Соединения и композиции в качестве ингибиторов протеинкиназы
|
CA2570552A1
(en)
|
2004-06-28 |
2006-01-05 |
Altana Pharma Ag |
4,6-disubstituted pyrimidines and their use as protein kinase inhibitors
|
US7253167B2
(en)
|
2004-06-30 |
2007-08-07 |
Bristol-Myers Squibb Company |
Tricyclic-heteroaryl compounds useful as kinase inhibitors
|
TW200616974A
(en)
|
2004-07-01 |
2006-06-01 |
Astrazeneca Ab |
Chemical compounds
|
CN1980911A
(zh)
|
2004-07-01 |
2007-06-13 |
默克公司 |
有丝分裂驱动蛋白抑制剂
|
CA2571572A1
(en)
|
2004-07-01 |
2006-01-19 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
EP1781653A1
(en)
|
2004-07-05 |
2007-05-09 |
Astex Therapeutics Limited |
3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors
|
CA2571937A1
(en)
|
2004-07-08 |
2006-02-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Pyrimidine derivatives useful as inhibitors of pkc-theta
|
US20080221157A1
(en)
|
2004-07-12 |
2008-09-11 |
Istituto Di Ricerche Di Biologia Molecolare P Ange |
Amide Derivatives as Inhibitors of Histone Deacetylase
|
WO2006005955A1
(en)
|
2004-07-12 |
2006-01-19 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Amide derivatives as inhibitors of histone deacetylase
|
DE102004034623A1
(de)
|
2004-07-16 |
2006-02-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2006036266A1
(en)
|
2004-07-16 |
2006-04-06 |
Sunesis Pharmaceuticals, Inc. |
Thienopyrimidines useful as aurora kinase inhibitors
|
WO2006012624A2
(en)
|
2004-07-21 |
2006-02-02 |
The Regents Of The University Of California |
Mechanism-based crosslinkers
|
EP1781647A2
(en)
|
2004-07-22 |
2007-05-09 |
Astex Therapeutics Limited |
Thiazole and isothiazole derivatives as protein kinase inhibitors
|
CN101023082A
(zh)
|
2004-07-22 |
2007-08-22 |
阿斯利康(瑞典)有限公司 |
用于治疗和预防癌症的稠合嘧啶酮类
|
AU2005269386A1
(en)
|
2004-07-27 |
2006-02-09 |
Sgx Pharmaceuticals, Inc. |
Pyrrolo-pyridine kinase modulators
|
US20090239214A1
(en)
|
2004-07-30 |
2009-09-24 |
Hongyue Dai |
Prognosis of breast cancer patients
|
CA2575808A1
(en)
|
2004-08-02 |
2006-02-16 |
Osi Pharmaceuticals, Inc. |
Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
|
US20060141549A1
(en)
|
2004-08-03 |
2006-06-29 |
Sudipta Mahajan |
Cell-based kinase assay
|
WO2006023083A1
(en)
|
2004-08-12 |
2006-03-02 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
AR050917A1
(es)
|
2004-08-13 |
2006-12-06 |
Amphora Discovery Corp |
Compuestos basados en 2-amido-tiazol que presentan actividad inhibidora de enzimas que utilizan atp, y composiciones y usos de los mismos
|
US7732472B2
(en)
|
2004-08-18 |
2010-06-08 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
EP1781286A4
(en)
|
2004-08-18 |
2009-06-10 |
Merck & Co Inc |
INHIBITORS OF MITOTIC KINESIN
|
US7550598B2
(en)
|
2004-08-18 |
2009-06-23 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
US7521457B2
(en)
|
2004-08-20 |
2009-04-21 |
Boehringer Ingelheim International Gmbh |
Pyrimidines as PLK inhibitors
|
CN101217958A
(zh)
|
2004-08-23 |
2008-07-09 |
默克公司 |
Akt活性抑制剂
|
WO2006021547A1
(de)
|
2004-08-26 |
2006-03-02 |
Boehringer Ingelheim International Gmbh |
Pteridinone als plk (polo like kinase) inhibitoren
|
MY191349A
(en)
|
2004-08-27 |
2022-06-17 |
Bayer Pharmaceuticals Corp |
New pharmaceutical compositions for the treatment of hyper-proliferative disorders
|
EP1784406A1
(de)
|
2004-08-27 |
2007-05-16 |
Boehringer Ingelheim International GmbH |
Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
|
EP1786265A4
(en)
|
2004-08-30 |
2009-08-19 |
Smithkline Beecham Corp |
NEW COMPOSITIONS AND PROCESSING METHODS
|
JP2008511600A
(ja)
|
2004-09-01 |
2008-04-17 |
アストラゼネカ アクチボラグ |
キナゾリン誘導体およびB−Raf抑制剤としてそれらの使用
|
GB0419416D0
(en)
|
2004-09-01 |
2004-10-06 |
Inst Of Ex Botany Ascr |
4-Arylazo-3,5-Diamino-Pyrazole compounds and use thereof
|
AR050926A1
(es)
|
2004-09-03 |
2006-12-06 |
Astrazeneca Ab |
Derivados de benzamida como inhibidores de la histonadesacetilasa(hdac)
|
TW200624431A
(en)
|
2004-09-24 |
2006-07-16 |
Hoffmann La Roche |
Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
|
EP1796467A4
(en)
|
2004-09-24 |
2009-07-01 |
Janssen Pharmaceutica Nv |
INHIBITORS IMIDAZO {4,5-B} PYRAZINONE PROTEIN KINASES
|
US20060069101A1
(en)
|
2004-09-27 |
2006-03-30 |
Kim Kyoung S |
Prodrugs of protein tyrosine kinase inhibitors
|
CA2581375A1
(en)
|
2004-09-27 |
2006-04-06 |
Kosan Biosciences Incorporated |
Specific kinase inhibitors
|
CA2582235A1
(en)
|
2004-10-04 |
2006-04-20 |
Millennium Pharmaceuticals, Inc. |
Lactam compounds useful as protein kinase inhibitors
|
FR2876377B1
(fr)
|
2004-10-11 |
2007-03-16 |
Univ Claude Bernard Lyon |
Nouveaux derives de 9h-pyrido[2,3-b]indole, leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes
|
MX2007004403A
(es)
|
2004-10-12 |
2007-04-27 |
Astrazeneca Ab |
Derivados de quinazolina.
|
MX2007004480A
(es)
|
2004-10-15 |
2007-05-08 |
Astrazeneca Ab |
Quinoxalinas como inhibidores b raf.
|
KR20070072562A
(ko)
|
2004-10-29 |
2007-07-04 |
반유 세이야꾸 가부시끼가이샤 |
오로라 a 선택적 억제 활성을 갖는 신규한 아미노피리딘유도체
|
US7855205B2
(en)
|
2004-10-29 |
2010-12-21 |
Janssen Pharmaceutica Nv |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
MX2007006103A
(es)
|
2004-11-22 |
2007-07-20 |
Vertex Pharma |
Pirrolopirazinas y pirazolopirazinas de utilidad como inhibidores de proteinquinasas.
|
GB0427917D0
(en)
|
2004-12-21 |
2005-01-26 |
Astrazeneca Ab |
Chemical compounds
|
ITPI20040099A1
(it)
|
2004-12-24 |
2005-03-24 |
Maurizio Pacini |
Sistema di realizzazione di tappeto erboso mediante micro-plantule preradicate
|
WO2006070198A1
(en)
|
2004-12-30 |
2006-07-06 |
Astex Therapeutics Limited |
Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
|
US20080312223A1
(en)
|
2004-12-30 |
2008-12-18 |
Astex Therapeutics Limited |
Thiazole And Isothiazole Derivatives That Modulate The Activity Of CDK, GSK And Aurora Kinases
|
AU2005321091B2
(en)
|
2004-12-30 |
2012-04-12 |
Astex Therapeutics Limited |
Pyrazole compounds that modulate the activity of CDK, GSK and Aurora kinases
|
GB0500492D0
(en)
|
2005-01-11 |
2005-02-16 |
Cyclacel Ltd |
Compound
|
GB0504474D0
(en)
|
2005-03-04 |
2005-04-13 |
Astrazeneca Ab |
Chemical compounds
|
GB0504475D0
(en)
|
2005-03-04 |
2005-04-13 |
Astrazeneca Ab |
Chemical compounds
|
FR2882751B1
(fr)
|
2005-03-04 |
2007-09-14 |
Aventis Pharma Sa |
Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, procede de preparation, compositions les contenant et utilisation
|
FR2884821B1
(fr)
|
2005-04-26 |
2007-07-06 |
Aventis Pharma Sa |
Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
|
GB0509224D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of intracellular enzymatic activity
|
GB0509227D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Intracellular enzyme inhibitors
|
GB0509223D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
US7541367B2
(en)
|
2005-05-31 |
2009-06-02 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
JP2008542433A
(ja)
|
2005-06-09 |
2008-11-27 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
CDK−1インヒビターとしてのα−カルボリン
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
WO2008016184A1
(en)
|
2006-08-02 |
2008-02-07 |
Takeda Pharmaceutical Company Limited |
Alpha-carboline derivatives and methods for preparation thereof
|
WO2008045834A2
(en)
|
2006-10-09 |
2008-04-17 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
EP2223925A1
(en)
*
|
2006-10-09 |
2010-09-01 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
US20100120717A1
(en)
*
|
2006-10-09 |
2010-05-13 |
Brown Jason W |
Kinase inhibitors
|
WO2008054956A2
(en)
|
2006-10-09 |
2008-05-08 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
US20090312288A1
(en)
*
|
2008-04-16 |
2009-12-17 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|